Cnb Bank Zymeworks Inc. Transaction History

Cnb Bank

  • $213 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$29.83 - $56.81 $23,118 - $44,027
-775 Closed
0 $0
Q2 2020

Jul 14, 2020
BUY
$33.67 - $40.0 $14,309 - $17,000
425 Added 121.43%
775 $28,000
Q4 2019

Jan 27, 2020
BUY
$24.84 - $45.46 $8,694 - $15,911
350 New
350 $16,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $856M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Cnb Bank Portfolio

Follow Cnb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email